What is the Knight ADRC Clinical Trials Unit?
The Washington University in St. Louis Knight Alzheimer’s Disease Research Center (ADRC) Clinical Trials Unit is one of more than 80 GAP-Net sites working with the Global Alzheimer’s Platform Foundation to accelerate Alzheimer’s disease clinical research. By volunteering for a study, you join the fight to prevent or cure Alzheimer’s disease and impact the future of medicine.
Trials Unit by the Numbers:
- 30 years of experience
- 100 clinical trials
- 5,300 participants
Alzheimer’s in Missouri:
- 1 in 8 people over age 65
- 110,000 people currently
- 130,000 people by 2025
Interested in Participating?
If you are interested in learning more about clinical trials studying investigational medicines to delay or slow the progression of Alzheimer’s disease, click the button below to learn more!
The Knight ADRC Clinical Trials Unit works with our amazing research volunteers to conduct clinical trials for the most promising new drugs for the treatment of Alzheimer disease and other dementias. Together, we are moving towards a world without Alzheimer disease and other dementias.
Joy Snider, MD, PhD, Professor of Neurology
Director of the Knight ADRC Clinical Trials Unit